Heron Therapeutics
Clinical trials sponsored by Heron Therapeutics, explained in plain language.
-
New shot battles Chemo's worst side effect
Symptom relief CompletedThis study tested whether a new drug combination (APF530) works better than a standard one (ondansetron) at preventing nausea and vomiting in cancer patients receiving strong chemotherapy. It involved 942 adults who were about to start their first round of this type of treatment.…
Phase: PHASE3 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Apr 06, 2026 14:14 UTC
-
Heart safety check for nausea drug in healthy volunteers
Knowledge-focused CompletedThis study looked at whether APF530, a drug for nausea, causes heart rhythm changes. Fifty-six healthy adults received APF530, a placebo, or other drugs in random order. Researchers measured heart activity with ECGs and blood samples. The goal was to see if APF530 is safe for the…
Sponsor: Heron Therapeutics • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC